Evidence map›Paper›PMID 32068895›Full record

Trial reportJournal of clinical psychology2020

Levels of distress tolerance in schizophrenia appear equivalent to those found in borderline personality disorder.

Kelsey A Bonfils, Paul H Lysaker

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical psychology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kelsey A BonfilsVISN 4 Mental Illness Research, Education, & Clinical Center (MIRECC), VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.ORCID 0000-0002-8556-5961
Paul H LysakerRichard L. Roudebush VA Medical Center, Indianapolis, Indiana.ORCID 0000-0002-6617-9387
Richard L. Roudebush VA Medical Center · USUniversity of Pittsburgh · US

Funding

Randomized Controlled Trial of Treatment for Internalized Stigma in SchizophreniaR01MH094310 · NIMH · JOHN JAY COLLEGE OF CRIMINAL JUSTICE · PI YANOS, PHILIP T · 2013 to 2016
$2.4M
NIMH NIH HHS R01 MH094310
6 · The paper itself

Abstract

objectiveDistress tolerance is an important but understudied construct for those with schizophrenia-spectrum disorders. This study compared levels of distress tolerance between people diagnosed with schizophrenia and borderline personality disorder (BPD) to better characterize distress tolerance in schizophrenia-spectrum disorders.

methodUsing cross-sectional data, we examined group differences in distress tolerance in people with schizophrenia-spectrum disorders (n = 55) and BPD (n = 32) through mean comparison and equivalence analyses.

resultsOur results indicate that, in our data, distress tolerance did not differ between those with schizophrenia and those with BPD, and was in fact statistically equivalent between groups. In contrast, those with BPD tended to report more difficulty on some aspects of emotion regulation.

conclusionFindings from this study suggest that increased focus on distress tolerance is called for in research on schizophrenia. Furthermore, people with schizophrenia-spectrum disorders may benefit from interventions targeting distress tolerance.

Indexed as

Psychological DistressSchizophrenic PsychologyAdultBorderline Personality DisorderCross-Sectional StudiesEmotional RegulationFemaleHumansMaleMiddle Agedborderline personality disorderdistress toleranceemotion regulationpsychotic symptomsschizophrenia

Identifiers

PMID32068895
PMCPMC7725405
OpenAlexW3008740980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.